Related Experiment Videos
Frontotemporal dementia and mitochondrial DNA transitions
Manuela Grazina1, Filipe Silva, Isabel Santana
1Neurology Unit, University Hospital of Coimbra, 3000-075 Coimbra, Portugal.
Neurobiology of Disease
|March 10, 2004
Summary
Mitochondrial DNA (mtDNA) variants were identified in a patient with frontotemporal dementia (FTD). This finding suggests a potential role for mtDNA in FTD pathology, similar to its role in Alzheimer's disease.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Biology
Background:
- Frontotemporal dementia (FTD) is a common neurodegenerative disorder.
- Overlap exists between FTD and Alzheimer's disease (AD) neuropathologically and clinically.
- Mitochondrial DNA (mtDNA) alterations are implicated in AD pathogenesis.
Purpose of the Study:
- To investigate the potential involvement of mtDNA in FTD.
- To screen for mtDNA mutations in FTD patients, particularly those previously associated with AD and Parkinson's disease.
Main Methods:
- Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analysis targeting specific mtDNA NADH Dehydrogenase subunit 1 (ND1) gene regions.
- Assessment of mitochondrial respiratory chain complex I activity in patient leukocytes.
Main Results:
- Identified two mtDNA transitions in one FTD patient: a known 3316 G-to-A and a novel 3337 G-to-A mutation.
- Observed reduced mitochondrial respiratory chain complex I activity (36% of control mean) in the leukocytes of this patient.
- This is the first report of mtDNA variants in FTD patients.
Conclusions:
- mtDNA variants may play a role in the physiopathology of FTD.
- Further research is warranted to explore the link between mtDNA and FTD.
- These findings open new avenues for understanding FTD mechanisms.